Isotretinoin Bailleul (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in skin cells, altering gene expression that reduces the size and activity of sebaceous glands, lowers sebum production, normalizes follicular keratinization, and exerts anti‑inflammatory effects. These combined actions diminish the formation of comedones and inflammatory lesions characteristic of acne.

The dosage of Isotretinoin Bailleul is individualized. A qualified prescriber determines the appropriate strength, frequency, and duration based on the patient’s weight, severity of acne, and laboratory monitoring results. Patients should follow the prescribing physician’s instructions and not adjust the dose on their own.

Isotretinoin is classified as Pregnancy Category X because it is highly teratogenic. It must not be used by pregnant women, and effective contraception is required for women of child‑bearing potential during treatment and for at least one month after stopping. Use while breastfeeding is also contraindicated due to potential risk to the infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with oral antibiotics or topical retinoids, isotretinoin offers a disease‑modifying effect by permanently reducing sebaceous gland activity, leading to longer‑lasting remission after a finite course. However, it carries a higher risk profile, requiring careful monitoring and strict pregnancy prevention, whereas antibiotics are generally shorter‑term and have fewer severe systemic risks.

Store Isotretinoin Bailleul at temperatures below 25 °C in its original packaging. Protect the product from moisture, excessive heat and direct sunlight. Do not refrigerate unless the manufacturer’s label specifically indicates a need for cold‑chain storage.

Isotretinoin Bailleul is taken orally, usually with a meal or a glass of milk to improve absorption and reduce gastrointestinal discomfort. The exact dosing schedule—once daily or divided doses—depends on the prescriber’s instructions and the patient’s individual treatment plan.

The most serious risks include teratogenicity (birth defects if taken during pregnancy), severe depression or suicidal thoughts, significant liver enzyme elevations indicating hepatotoxicity, and marked hypertriglyceridemia that can lead to pancreatitis. Patients should be monitored closely for these events and seek immediate medical attention if they occur.

Individuals who are pregnant, planning to become pregnant, or not using reliable contraception should not use isotretinoin. It is also contraindicated in patients with pre‑existing liver disease, uncontrolled hyperlipidaemia, or those taking other high‑dose vitamin A products. A thorough medical assessment is required before initiating therapy.